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Color-stable water-dispersed cesium lead halide
perovskite nanocrystals†
Leyre Gomez,*a Chris de Weerd,a Jose L. Huesob,c and Tom Gregorkiewicza
Cesium lead halide perovskite nanocrystals are being lately explored for optoelectronic applications due
to their emission tunability, high photoluminescence quantum yields, and narrow emission bands.
Nevertheless, their incompatibility with polar solvents and composition homogenization driven by a fast
anion-exchange are still important drawbacks to overcome. Herein we report on a successful encapsula-
tion of colloidal perovskite nanocrystals within solid–lipid structures mainly consisting of stearic acid. The
product is water-stable for a period longer than 2 months and anion-exchange is fully arrested when
mixing nanocrystals of different halide compositions. This strategy boosts the potential applications of all-
inorganic perovskite nanocrystals for ink-printing.
Introduction
All-inorganic perovskite nanocrystals (NCs) made of cesium
lead halide (CsPbX3, X = Cl, Br and I) have attracted much
attention during the past year due to their emission tunability,
high photoluminescence quantum yields (PL QYs = 50–90%)
and narrow emission bands.1–4 These recently discovered
cubic nanoparticles combine the properties of perovskites5,6
(high emission efficiencies and low temperature production)
and quantum dots7,8 (QDs, quantum-size effects) making
them suitable for different optoelectronic applications (LEDs,
solar cells, lasing).9–14 Despite these attractive features, perov-
skite NCs also exhibit some important limitations, such as
moisture and air instability, the presence of the toxic element
lead, thermal decomposition, etc.15,16 Herein, we focus our
research on two major inherent drawbacks: (i) incompatibility
with polar solvents and (ii) fast anion-exchange when mixed.
Colloidal perovskite NCs lose their structural integrity in
the presence of polar solvents due to their inherent ionic struc-
ture and the dynamic stabilization of the surface ligands (oleyl-
ammonium bromide, oleylammonium oleate and oleylamine)
which involves fast desorption.17 There have been recent
efforts to enhance their stability in air using a new surface pas-
sivation technique based on the use of an inorganic–organic
ion pair, which helps to slow down the NC degradation against
atmospheric moisture.18 The use of branch-structured capping
ligands has been also shown to improve their stability in polar
solvents.19 X-ray lithography has been used on NC films to
form intermolecular bonds between the organic surface
ligands achieving, however, only a few days of stabilization of
the film immersed in Milli-Q water or buffer saline.20 Besides,
the encapsulation of QDs by micelle formation of lipid mole-
cules21,22 has been widely studied. Nevertheless, water-resist-
ant CsPbX3 NCs have been obtained so far only by robust non-
porous coatings, such as silica spheres23 and polyhedral oligo-
meric silsesquioxane24 synthesized using water-free processes.
With an eye on optoelectronic applications, it is necessary
that NCs of different compositions maintain their own emis-
sion characteristics when mixed. However, this is currently
impossible as a fast anion-exchange (10–20 minutes) takes
place, leading to composition homogenization.25,26 For
instance, mixing CsPbBr3 and CsPbI3 NCs at room temperature
will yield CsPb(BrI)3 NCs, and the product PL emission will be
centered in between those of the initial materials. This color
instability renders perovskite NCs not suitable for many
imaging applications where the presence of different colors is
required in order to cover the spectral range visible to the
human eye.27–29
To overcome these limitations, here we report on the encap-
sulation of colloidal cesium lead halide perovskite NCs within
solid lipid nanoparticles (SLNs).30,31 SLNs are made of lipids –
which are solid at room temperature – and stabilized by
emulsifiers in water. They are commonly used as drug carrier
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systems since they offer advantages such as a high drug
payload, increased drug stability, controlled drug release, non-
toxicity, feasibility of sterilization and lyophilization, and the
possibility of large scale production. In addition, SLNs have
already been used for the encapsulation of colloidal Si NCs32
and Au nanoparticles33 for fluorescence cell labeling purposes.
We demonstrate that the colloidal encapsulation of perovskite
NCs by SLNs renders them water-stable and arrests com-
position homogenization for at least 2 months, which is long
enough for most applications.
Experimental
Chemicals
Cesium carbonate (Cs2CO3, 99.9%, Sigma-Aldrich), octadecene
(ODE, 90%, Sigma-Aldrich), oleic acid (OA, 90%, Sigma-
Aldrich), oleylamine (OLA, 80–90%, Acros), lead(II) bromide
(PbBr2, 98%, Sigma-Aldrich), lead(II) chloride (PbCl2, 98%,
Sigma-Aldrich), lead(II) iodide (PbI2, 99%, Sigma-Aldrich),
toluene (ACS reagent ≥99.5%, Sigma-Aldrich), stearic acid
(95%, Sigma-Aldrich), and Poloxamer 188 (Kolliphor® P188,
Sigma-Aldrich). All chemicals were used with no further purifi-
cation, except for the drying period reported in the perovskite
nanocrystal synthesis procedure.
Perovskite nanocrystal synthesis
Cesium lead halide perovskites (CsPbX3) were synthesized as
described by Protesescu et al.1 First, Cs-oleate was prepared by
mixing 0.814 g of Cs2CO3 with 40 mL of ODE and 2.5 mL of
OA; all reactants were dried at 120 °C for 1 h. The mixture was
stirred at 150 °C under a N2 atmosphere until reaction com-
pletion was evidenced by complete dissolution of the cesium
carbonate. Briefly, 5 mL of ODE and 0.188 mmol of the corres-
ponding lead(II) halide (PbCl2, PbBr2, or PbI2) were dried for
1 h at 120 °C under a N2 atmosphere. After water removal,
0.5 mL of dried OLA and 0.5 mL of dried OA were added to the
reaction flask and the temperature was raised up to 160 °C.
After complete dissolution of the lead salt, 0.4 mL of the
Cs-oleate solution previously warmed up was injected. A few
seconds later, the NC suspension was quickly cooled down
with an ice bath. The product was purified by centrifugation
and redispersed in 6 mL of toluene and stored for further use.
Encapsulation of the NCs in solid–lipid structures
For an optimized and homogeneous encapsulation, 1 mL of
the dispersed perovskite NCs in toluene (20 mg mL−1) were
mixed with 1.5 mg of stearic acid and the mixture was heated
up to 75 °C in order to melt the lipid (∼10 min). Thereafter,
the organic dispersion was added to a water solution of 0.5 wt%
P188 in the volume ratio 1 : 5 and the two phase system was
sonicated for 5 min in a cold water bath (∼10 °C). The micro-
emulsion was stirred at room temperature overnight in an
open vessel to let the toluene evaporate. Then, the product was
washed twice by centrifugation (5000 rpm, 10 minutes) and
redispersed in Milli-Q water.
Characterization
Transmission and Scanning Transmission Electron Microscopy
(TEM-STEM) images were taken with a high resolution
Scanning Electron Microscope (SEM, FEI Verios 460) using the
STEM detector and with the aid of a FEI Tecnai F30 and an
aberration-corrected FEI XFEG TITAN electron microscope oper-
ated at 300 kV using a high angle annular dark field detector
equipped with a CETCOR Cs-probe corrector from CEOS
Company allowing the formation of an electron probe of
0.08 nm. The geometric aberrations of the probe-forming
system were controlled to allow a beam convergence of
24.7 mrad half-angle to be selected. Preliminary electron
microscopy observations were completed with a T20-FEI micro-
scope with a LaB6 electron source fitted with a “SuperTwin®”
objective lens. The sizes of the SLNs and NCs were statistically
estimated by measuring the STEM and TEM images using the
software ImageJ (N = 200). The optical density of the investi-
gated colloids was measured using a LAMBDA 950 UV/Vis/NIR
spectrophotometer (PerkinElmer). The PL spectra were
recorded by using a Jobin Yvon FluoroLog spectrofluorometer
(Horiba) equipped with a 450 W xenon lamp (250–700 nm)
coupled to a monochromator, to provide a range of selected
excitation wavelengths. The emission spectra were collected in
a right-angle geometry and subsequently scaled for the exci-
tation intensity, and corrected for spectral sensitivity of the
detector. The PL QY has been determined using an integrating
sphere with a 150 W xenon lamp coupled to a spectrometer
(Solar, MSA-130) as an excitation source. The emission and
excitation light is scattered diffusively in the integrating sphere
and detected by using a CCD (Hamamatsu S10141-1108S)
coupled to a second spectrometer (Solar, M266).34 The pico-
second PL dynamics have been measured using the frequency-
doubled output of a tunable Ti:sapphire laser system
(Chameleon Ultra, Coherent), providing 140 fs pulses at Eexc =
2.88 eV. A pulse picker has been employed to reduce the rep-
etition rate from 80 MHz to 8 MHz. The PL emission has been
detected using a monochromator (Newport CS260-02) coupled
to a PMT (Hamamatsu) providing a total detection range of
Edet = 6–1.6 eV. The overall instrument response function (IRF)
was 20–25 ps (FWHM), as measured from a dilute scattering
solution (Ludox) at the excitation wavelength. All measure-
ments have been performed at room temperature.
Results and discussion
CsPbX3 perovskite NCs with different halide compositions
were synthesized following the procedure described by
Protesescu et al.,1 yielding a stable colloidal product dispersed
in toluene. The absorption and emission of these perovskites
can be tuned along the visible range by changing the halide
composition, producing purple-, green- and red-emitting NCs
(X = Cl, Br, and Br0.2I0.8, respectively, see Fig. 1a) with high PL
QYs (QYCl = 52%, QYBr = 85%, QYBrI = 33%). In order to
increase the stability of the red emitting NCs (the cubic
phase of CsPbI3 is typically metastable, recrystallizing into a
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non-emissive yellow phase)35 we added 20 mol% of Br ions.
CsPbX3 NCs show a cubic structure (Fig. 1b) and their size
can be tuned from 4 to 15 nm by the reaction temperature
(140–200 °C). Nevertheless, other shape structures (rods, dots,
etc.) can be found in the sample as subproducts of the
synthesis (see ESI, Fig. 1S†). The PL lifetimes are in the order
of ns as reported previously1 (Fig. 2S†).
SLNs loaded with perovskite NCs were prepared by soni-
cation-assisted melt homogenization (see the Experimental
section and Scheme 1).36–38 As the lipid matrix we chose
stearic acid, a saturated C18 fatty acid, since it is commonly
used as a drug carrier because its melting point of 69.6 °C is
higher than the human body temperature.36,37,39,40 As an
emulsifier we used the surfactant Poloxamer 188 (a non-ionic
triblock copolymer) without a co-surfactant. Briefly, the stearic
acid was melted in a toluene solution containing the nanocrys-
tals, and the mixture was transferred to the emulsifier water
solution. Then, the two-phase suspension was sonicated in a
cold water-bath to create an emulsion and to solidify the
stearic acid. After toluene evaporation and sample centrifu-
gation, the final product redispersed in Milli-Q water shows an
opaque white color while the characteristic emission of the
perovskite NCs can be observed under UV lamp illumination
(insets in Fig. 2b and d). The SLNs with perovskite NCs were
visualized by STEM and TEM showing a platelet-like
shape.30,41 The first fabrication attempt resulted in lipid struc-
tures of heterogeneous sizes, ranging from several nm to 5 μm
(Fig. 2a). By subsequent adjustments and improvements in the
SLN synthesis (reducing the amount of lipid and decreasing
the temperature of the sonication bath), we managed to reduce
the platelet size and improve the size distribution. The solid
lipid platelets randomly dispersed on the TEM grid have an
average size of 700 ± 240 nm (Fig. 2b). In addition, some rod-
shaped particles can also be seen in Fig. 2b. As described
before, these typically appear as a subproduct in the NC syn-
thesis and can be purposefully synthesized by adjusting the
reaction time and temperature.3 When High Angle Annular
Dark Field (HAADF)-STEM analysis is performed on a layered
solid lipid platelet, we can see the perovskite NCs embedded
in the matrix (Fig. 2c and d). We observe a decrease in the size
Fig. 1 (a) Absorption and photoluminescence spectra of three different halide composition perovskites CsPbX3 (X = Cl, Br, Br0.2I0.8) in toluene; the
inset shows the corresponding emission colors under UV lamp irradiation (365 nm). (b) STEM image of CsPbBr3 nanocrystals dropcasted on a copper
grid.
Scheme 1 Procedure for the encapsulation of CsPbBr3 perovskite nanocrystals (with oleylamine as a surface ligand) in a solid lipid matrix of stearic
acid by sonication-assisted melt homogenization (see the Experimental section).
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of the NCs after the encapsulation process, from 7.2 ± 1.4 nm
to 3.8 ± 0.7 nm for the green emitting sample (fresh NCs
Fig. 1b and after encapsulation Fig. 2d) and the cubic shape
becomes somewhat rounded up.
We compare the water-stability of free-standing and encap-
sulated perovskite NCs by recording the PL intensity as a func-
tion of time (Fig. 3, 3S and 4S†). Colloidal NCs in contact with
Milli-Q water disintegrate within a few minutes (5–15 min) and
their PL vanishes. In particular, the disintegration of CsPbCl3
NCs transforms the available ions into blue emitting CsCl with
a wider emission peak than the initial material (Fig. 3Sc†).42
On the other hand, CsPbBr3 and CsPb(Br0.2I0.8)3 encapsulated
NCs dispersed in Milli-Q water still emit light after 2 months.
The encapsulation of CsPbCl3 was not successful as these NCs
disintegrated before the lipid capsules were made (Fig. 4Sc,†
broad emission of CsCl instead of a narrow peak from pero-
vskite NCs). At the same time, a decrease of the NC PL inten-
sity over time is observed, most pronounced for CsPbBr3,
being related with the precipitation of agglomerates. SLNs may
form larger structures by the phenomenon known as gelation
which can be stimulated by different situations such as insuffi-
cient stabilization, removal of the emulsifier from the particle
surface by dilution, or intense contact between the SLN due to
high concentration or contact with other surfaces.30 According
to our observations, storage time and exposure to an excitation
source during photoluminescence experiments induce agglom-
eration and precipitation of the SLNs. Nevertheless, TEM and
STEM images of the NCs embedded in the lipid matrix were
taken 5 months after the sample was dropcasted onto the grid,
showing that the NCs are still clearly visible.
After the encapsulation process, the PL maximum of the
ensemble spectra blue-shifts for both, CsPbBr3 and CsPb
(Br0.2I0.8)3, with respect to the PL spectra of the initial dis-
persion of NCs in toluene (Fig. 6S†). This PL blue-shift can be
explained by the earlier-mentioned size reduction of the NCs
due to surface degradation during the encapsulation process.
Besides the change in the NC size, a mechanical compression
induced by the capsules, and/or a change in the electrical
field could help to enhance the PL blue-shift.38,43 Similar
observations have been made before for micelle encapsulated
quantum dots (QDs) and core–shell QDs.44,45 The PL lifetime
of the encapsulated perovskite NCs remains in the order of ns
(Fig. 2S†) while the PL QY decreases after the encapsulation
process (QYBr–SLN = 13%, QYBrI–SLN = 9%). The change in the
PL QY suggests NC degradation during the encapsulation
process, as we have perceived from the HRTEM images. The
NC degradation takes place because they are in direct contact
Fig. 2 (a) TEM image of a heterogeneous sample of stearic acid SLN
with CsPbBr3 nanocrystals inside. (b) TEM image of CsPbBr3 embedded
in platelet-like shape structures with an average size of 700 ± 240 nm
(N = 150), some fibers can be also observed; the inset shows the sample
illuminated with room light. (c) HAADF-STEM image of the perovskite
nanocrystals embedded in lipid platelets. (d) HAADF-STEM zoom-in
image of a lipid structure (red circle of image c) where the perovskite
nanocrystals are visualized inside the matrix; the inset shows the green
emission of the sample under UV lamp (365 nm) illumination.
Fig. 3 Photoluminescence intensity as a function of time for free-standing (red) and encapsulated (black) CsPbBr3 (a) and CsPb(Br0.2I0.8)3 (b) nano-
crystals dispersed in Milli-Q water. PL intensity is normalized (100%) to the value in toluene before contact with Milli-Q water (red), and with the
emission of freshly prepared encapsulated perovskites (black). The lines are a guide to the eye.
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with water until the SLN is formed. It is worth noting that the
lipid matrix itself, without perovskite NCs, does not absorb
light in the studied region (see Fig. 7S†).
To investigate the effect of encapsulation on anion-
exchange and hence the color stability, two different types of
perovskite NCs embedded in SLNs were mixed in Milli-Q
water, and their PL was recorded as a function of time. As can
be concluded from Fig. 4, the maximum of the emission peak
of each sample (CsPbBr3 – 518 nm and CsPb(Br0.2I0.8)3 –
632 nm) remains in the same position even after 2 months.
This implies that composition homogenization does not
take place, with the process of anion-exchange being fully
arrested.
The achievement of emission and color-stable perovskite
NCs enables new uses of this material. The size is sufficiently
small to allow water-based ink-printing for optoelectronics46,47
or anti-counterfeiting,48 as nozzle diameters are typically of a
few tens of micrometers. For bio-imaging purposes,49,50
additional efforts should be carried out to further decrease the
size of the platelet lipid structures. To induce a cellular
response, any nanomaterial should be smaller than 100 nm,
although each nanoparticle has an effective size range depend-
ing on the bio-application.51 One way towards further size
reduction could be by the influence of the surfactant type and
concentration.52
Conclusions
Long-term emission and color stability have been demon-
strated for colloidal cesium lead halide perovskite NCs dis-
persed in Milli-Q water. These properties have been achieved
by encapsulation of perovskite NCs within SLNs of stearic acid.
In this way, an easy-to-handle material, with a non-toxic carrier
and free from organic solvents has been obtained. With that,
the potential applications of all-inorganic cesium lead halide
perovskite NCs are greatly increased; in particular, the pre-
paration of water-based inks for jet-printing appears feasible.
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